SEC-sourced researchBeta
QTTB
Q32 Bio Inc.
Company comparison ↗
Data passport
- CIK
- 0001661998
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Sep 30, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 0.0000 | Mar 10, 2026 |
| December 2025 | 53,737,000.0000 | Mar 10, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 53,737,000.0000 | 29,821,000.0000 | -33,543,000.0000 | 61,776,000.0000 | 19,762,000.0000 | Mar 10, 2026 |
| December 2024 | 0.0000 | -47,733,000.0000 | -67,715,000.0000 | 92,332,000.0000 | 86,657,000.0000 | Mar 10, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $53.74M | December 2025 | Mar 10, 2026 | 10-K |
| Previous period revenueRevenues | $0 | December 2024 | Mar 10, 2026 | 10-K |
| Net incomeNetIncomeLoss | $29.82M | December 2025 | Mar 10, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$33.54M | December 2025 | Mar 10, 2026 | 10-K |
| Total assetsAssets | $61.78M | December 2025 | Mar 10, 2026 | 10-K |
| Total liabilitiesLiabilities | $19.76M | December 2025 | Mar 10, 2026 | 10-K |